Mediaspace scheduled maintenance: Aug 25, 2026 07:00 - 12:00 AM. During this time, videos will be temporarily unavailable. Check status updates.

Lecture

Production of Viral Vectors

Description

This lecture covers the production of viral vectors for gene therapy applications, focusing on adeno-associated virus (AAV) vectors. Topics include vector plasmids, regulatory sequences, AAV helper plasmids, adenovirus helper plasmids, transgene expression, serotypes, and production efficiency. The process involves large-scale production, purification, and quality control under Good Manufacturing Practice conditions.

In MOOC

Neuroscience Reconstructed: Genetics and Brain Development

Official source

Ontological neighbourhood

Biology

Molecular biology: Topics in molecular biology

Related concepts (29)

Viral vector

Viral vectors are tools commonly used by molecular biologists to deliver genetic material into cells. This process can be performed inside a living organism (in vivo) or in cell culture (in vitro). Viruses have evolved specialized molecular mechanisms to efficiently transport their genomes inside the cells they infect. Delivery of genes or other genetic material by a vector is termed transduction and the infected cells are described as transduced. Molecular biologists first harnessed this machinery in the 1970s.

Vector (molecular biology)

In molecular cloning, a vector is any particle (e.g., plasmids, cosmids, Lambda phages) used as a vehicle to artificially carry a foreign nucleic sequence – usually DNA – into another cell, where it can be replicated and/or expressed. A vector containing foreign DNA is termed recombinant DNA. The four major types of vectors are plasmids, viral vectors, cosmids, and artificial chromosomes. Of these, the most commonly used vectors are plasmids. Common to all engineered vectors are an origin of replication, a multicloning site, and a selectable marker.

Adeno-associated virus

Adeno-associated viruses (AAV) are small viruses that infect humans and some other primate species. They belong to the genus Dependoparvovirus, which in turn belongs to the family Parvoviridae. They are small (approximately 26 nm in diameter) replication-defective, nonenveloped viruses and have linear single-stranded DNA (ssDNA) genome of approximately 4.8 kilobases (kb). Several features make AAV an attractive candidate for creating viral vectors for gene therapy, and for the creation of isogenic human disease models.

Gene delivery

Gene delivery is the process of introducing foreign genetic material, such as DNA or RNA, into host cells. Gene delivery must reach the genome of the host cell to induce gene expression. Successful gene delivery requires the foreign gene delivery to remain stable within the host cell and can either integrate into the genome or replicate independently of it. This requires foreign DNA to be synthesized as part of a vector, which is designed to enter the desired host cell and deliver the transgene to that cell's genome.

Gene therapy

Gene therapy is a medical technology which aims to produce a therapeutic effect through the manipulation of gene expression or through altering the biological properties of living cells. The first attempt at modifying human DNA was performed in 1980, by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.

Related lectures (30)

Preclinical and Clinical Trials in SMA Gene Therapy MOOC: Neuroscience Reconstructed: Genetics and Brain Development

Explores preclinical and clinical trials in SMA gene therapy, including efficiency in patients, trial results, adverse effects, cellular targeting, and future perspectives.

Types of Viral Vectors MOOC: Neuroscience Reconstructed: Genetics and Brain Development

Explores the properties of commonly used viral vectors for gene therapy.

Choosing a Viral Vector and Delivery Method MOOC: Neuroscience Reconstructed: Genetics and Brain Development

Discusses viral vector selection for gene therapy, with a focus on AAV vectors for SMA1 therapy and CNS delivery.

Gene Therapy for CNS and Sensory Organs

Explores gene therapy for CNS and sensory organs, focusing on rare genetic diseases and advancements in precision medicine.

Approaches in Gene Therapy MOOC: Neuroscience Reconstructed: Genetics and Brain Development